Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, presented new data at the Union World Conference on ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Democratic governors and attorneys general are set to reprise their roles in battling President-elect Trump's policies.

November 12, 2024NeuroPace, Inc. beats earnings expectations. Reported EPS is $-0.19, expectations were $-0.27. Operator: ...

Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...

DN-TNF product candidates are in clinical trials to determine if they can treat cancer (INB03™), Mild Alzheimer’s disease, Mild Cognitive Impairment and treatment-resistant depression (XPro ... start ...

Tabia Health, Inc. (Tabia) today announced plans to combine American Heart Association CarePlans into Tabia's AI-powered healthcare orchestration platform to improve CarePlan utilization and patient ...